71| Volume 381, SUPPLEMENT , 21, October 15, 2017

Exome sequencing for neurological disorders

      DNA sequencing for the diagnosis of human disease has developed at a rapid pace. While the cost of whole genome sequencing using next generation sequencing technology has continue to decrease, the use of whole exome sequencing continues to be of great value, especially in a clinical setting. This is because the majority of Mendelian disorders continue to be in coding regions, and the effect of single base pair changes are still best understood in the exome. In this talk we will compare whole genome and whole exome analyses and discuss the advantages of the different types of exome panels available clinically. We will briefly demonstrate some useful tools for evaluation of families and present several successful exome studies.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect